{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:21:01Z","timestamp":1789993261403,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1987,3,1]],"date-time":"1987-03-01T00:00:00Z","timestamp":541555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1987,3]]},"DOI":"10.1007\/bf01715847","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T02:24:51Z","timestamp":1118543091000},"page":"213-217","source":"Crossref","is-referenced-by-count":8,"title":["Naloxone in treatment of circulatory shock resistant to conventional therapy"],"prefix":"10.1007","volume":"65","author":[{"given":"B.","family":"Allolio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kaulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Deu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01715847_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1530\/acta.0.0970098","volume":"96","author":"B Allolio","year":"1981","unstructured":"Allolio B, Winkelmann W, Hipp FX (1981) Effect of meclastine, an H1-antihistamine, on plasma ACTH in adrenal insufficiency. Acta Endocrinol (Kbh) 96:98\u2013102","journal-title":"Acta Endocrinol (Kbh)"},{"key":"BF01715847_CR2","first-page":"290","volume":"44","author":"EW Bernton","year":"1985","unstructured":"Bernton EW, Long JB, Holaday JW (1985) Opioids and neuropeptides: mechanisms in circulatory shock. Fed Proc 44:290\u2013299","journal-title":"Fed Proc"},{"key":"BF01715847_CR3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/00003246-198511000-00039","volume":"13","author":"F Bonnet","year":"1985","unstructured":"Bonnet F, Bilaine J, Lhoste F, Mankikian B, Kerdelhue B, Rapin M (1985) Naloxone therapy of human septic shock. Crit Care Med 13:972\u2013975","journal-title":"Crit Care Med"},{"key":"BF01715847_CR4","first-page":"H416","volume":"239","author":"MT Curtis","year":"1980","unstructured":"Curtis MT, Lefer AM (1980) Protective actions of naloxone in hemorrhagic shock. Am J Physiol 239:H416-H421","journal-title":"Am J Physiol"},{"key":"BF01715847_CR5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(85)91787-8","volume":"I","author":"A Maria De","year":"1985","unstructured":"De Maria A, Craven DE, Heffernan JJ, McIntosh TK, Grindlinger GA, McCabe WR (1985) Naloxone versus placebo in treatment of septic shock. Lancet I:1363\u20131365","journal-title":"Lancet"},{"key":"BF01715847_CR6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(80)92418-6","volume":"II","author":"R Dirksen","year":"1980","unstructured":"Dirksen R, Otten MH, Wood GJ, Verbaan CJ, Haalebos MMP, Verdouw PV, Nijhuis GMM (1980) Naloxone in irreversible shock. Lancet II:1360\u20131361","journal-title":"Lancet"},{"key":"BF01715847_CR7","first-page":"441","volume":"212","author":"AI Faden","year":"1980","unstructured":"Faden AI, Holaday JW (1980) Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. J Pharmacol Exp Ther 212:441\u2013447","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01715847_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/142.2.229","volume":"142","author":"AI Faden","year":"1980","unstructured":"Faden AI, Holaday JW (1980) Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists. J Infect Dis 142:229\u2013238","journal-title":"J Infect Dis"},{"key":"BF01715847_CR9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.7455690","volume":"211","author":"AI Faden","year":"1981","unstructured":"Faden AI, Jacobs ThP, Holaday JW (1981) Opiate antagonist improves neurologic receovery after spinal injuny. Science 211:493\u2013494","journal-title":"Science"},{"key":"BF01715847_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00003246-198308000-00013","volume":"11","author":"JS Groeger","year":"1983","unstructured":"Groeger JS, Carlon GC, Howland WS (1983) Naloxone in septic shock. Crit Care Med 11:650\u2013654","journal-title":"Crit Care Med"},{"key":"BF01715847_CR11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.197601","volume":"197","author":"R Guillemin","year":"1977","unstructured":"Guillemin R, Vargo T, Rossier J, Minich S, Ling N, Rivier C, Vale W, Bloom F (1977) \u03b2-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197:1367\u20131369","journal-title":"Science"},{"key":"BF01715847_CR12","first-page":"63","volume":"10","author":"N Gurll","year":"1983","unstructured":"Gurll N (1983) Naloxone in endotoxic shock: experimental models and clinical perspective. Adv Shock Res 10:63\u201371","journal-title":"Adv Shock Res"},{"key":"BF01715847_CR13","first-page":"621","volume":"220","author":"NJ Gurll","year":"1982","unstructured":"Gurll NJ, Reynolds DG, Vargish T, Lechner RB (1982) Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock. J Pharmacol Exp Ther 220:621\u2013624","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01715847_CR14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.pa.23.040183.002545","volume":"23","author":"JW Holaday","year":"1983","unstructured":"Holaday JW (1983) Cardiovascular effects of endogenous opiate system. Annu Rev Pharmacol Toxicol 23:541\u2013594","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF01715847_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(80)90032-3","volume":"189","author":"JW Holaday","year":"1980","unstructured":"Holaday JW, Faden AI (1980) Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res 189:295\u2013299","journal-title":"Brain Res"},{"key":"BF01715847_CR16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/275450a0","volume":"275","author":"JW Holaday","year":"1978","unstructured":"Holaday JW, Faden AI (1978) Naloxone reversal of endotoxic hypotension suggests role of endorphins in shock. Nature 275:450\u2013451","journal-title":"Nature"},{"key":"BF01715847_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-47-1-160","volume":"47","author":"WJ Jeffcoate","year":"1978","unstructured":"Jeffcoate WJ, Rees LH, Lowry PJ, Besser GM (1978) A specific radioimmunoassay for human \u03b2-lipotropin. J Clin Endocrinol Metab 47:160\u2013166","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01715847_CR18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/0003-4819-85-6-765","volume":"85","author":"WR Martin","year":"1976","unstructured":"Martin WR (1976) Naloxone. Ann Intern Med 85:765\u2013768","journal-title":"Ann Intern Med"},{"key":"BF01715847_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(81)92865-8","volume":"I","author":"WP Peters","year":"1981","unstructured":"Peters WP, Johnson MW, Friedman PA, Mitch WE (1981) Pressor effect of naloxone in septic shock. Lancet I:529\u2013532.","journal-title":"Lancet"},{"key":"BF01715847_CR20","first-page":"159","volume":"152","author":"RM Raymond","year":"1981","unstructured":"Raymond RM, Harkema JM, Stoffs WV, Emerson ThE (1981) Effects of naloxone therapy on hemodynamics and metabolism following a supralethal dosage ofEscherichia coli endotoxin in dogs. Surg Gynecol Obstet 152:159\u2013162","journal-title":"Surg Gynecol Obstet"},{"key":"BF01715847_CR21","first-page":"39","volume":"7","author":"DG Reynolds","year":"1980","unstructured":"Reynolds DG, Gurll NJ, Vargish T, Lechner R, Faden AI, Holaday JW (1980) Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock. Circ Shock 7:39\u201348","journal-title":"Circ Shock"},{"key":"BF01715847_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00003246-198501000-00008","volume":"13","author":"P Rock","year":"1985","unstructured":"Rock P, Silverman H, Plump D, Kecala Z, Smith Ph, Michael JR, Summer W (1985) Efficacy and safety of naloxone in septic shock. Crit Care Med 13:28\u201333","journal-title":"Crit Care Med"},{"key":"BF01715847_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(80)92723-3","volume":"II","author":"M Tiengo","year":"1980","unstructured":"Tiengo M (1980) Naloxone in irreversible shock. Lancet II:690","journal-title":"Lancet"},{"key":"BF01715847_CR24","first-page":"31","volume":"7","author":"T Vargish","year":"1980","unstructured":"Vargish T, Reynolds DG, Gurll NJ, Lechner RB, Holaday JW, Faden AI (1980) Naloxone reversal of hypovolaemic shock in dogs. Circ Shock 7:31\u201338","journal-title":"Circ Shock"},{"key":"BF01715847_CR25","first-page":"1361","volume":"II","author":"DJM Wright","year":"1980","unstructured":"Wright DJM, Philips M, Weller MPI (1980) Naloxone in shock. Lancet II:1361","journal-title":"Lancet"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01715847\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:04:11Z","timestamp":1557306251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01715847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,3]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,3]]}},"alternative-id":["BF01715847"],"URL":"https:\/\/doi.org\/10.1007\/bf01715847","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,3]]}}}